We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

A Network of Transcription Factors Regulates Heart and Craniofacial Organ Development

By LabMedica International staff writers
Posted on 20 Nov 2012
An international team of researchers in the field of regenerative medicine have identified a set of transcription factors that functions as a hierarchical regulatory network, which initiates the formation of heart and craniofacial organs in the developing embryo.

They reported in the October 29, 2012, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that they had identified Lhx2 (LIM/homeobox protein) as a previously undescribed player during cardiac and pharyngeal muscle development.

Located in the pharyngeal mesoderm (PM), Lhx2 was found to interact genetically with two other cofactors, Tcf21 and Tbx1, the major determinant in the etiology of DiGeorge/velo-cardio-facial/22q11.2 deletion syndrome. Knockout of the genes encoding these transcription factors in mice resulted in animals with the specific cardiac features of this syndrome.

“Advances in regenerative medicine and developmental biology can now happen because we no longer require human embryos to generate stem cells,” said contributing author Dr. Chrissa Kioussi, associate professor of pharmacy at Oregon State University (Corvallis, USA). “The Nobel Prize this year was awarded to people who discovered how to make stem cells from adult biopsies.”

“In this work and in regenerative medicine, we care a great deal about all of these steps of cell differentiation,” said Dr. Kioussi. “If you know all the steps it takes to get from here to there, you can identify what went wrong and find ways to fix it. This is being done already with some disease problems, and this work will move us closer to being able to repair heart and craniofacial defects. Once we understand these genetic controls in sufficient detail, we can not only turn a skin cell into a stem cell, but also turn that stem cell into the type needed for the patient to recover. We may eventually be able to grow replacement organs from the patient’s cells.”

Related Links:
Oregon State University



New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Automated Blood Typing System
IH-500 NEXT
New
Silver Member
Static Concentrator
BJP 10
New
Serum Toxicology Benzodiazepine Assay
DRI Serum Toxicology Benzodiazepine Assay

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries